About Us


Tikun Olam Ltd. is the first, largest and foremost supplier of medical Cannabis in Israel, and globally recognized as the pioneer of modern medical cannabis.

Vision: Bringing Cure and Alleviation, Using Research Based and Clinically Proven Medical Cannabis Products to Patients Worldwide

Tikun Olam ("repair the world" in Hebrew) is privately held and has been operating under license from the Israel Ministry of Health since 2006. The company is a vertically integrated company from plant cultivation to patient administration.

Tikun Olam Grows medical cannabis cultivated in state-of-the-art standards. Tikun Olam has developed multiple proprietary award winning strains, including the first-ever, high-CBD, "high-less" strain Avidekel™, its popular high-THC strains Alaska™ and Erez™, and "one-to-one" CBD/THC strain Midnight™.

Tikun Olam Research holds unprecedented patient clinical data collection. The company products are used in ongoing clinical trials in Israel's regulated medical cannabis market.

Tikun Olam Care the world’s first professional cannabis nursing clinic; one of its most recognized achievements. Tikun Olam provides safe and personalized treatment for all ages ranging from pediatric to geriatric patients, treating over 20,000 patients for a variety of medical conditions.

Tikun Olam International scope

2014 - Co founded Medreleaf pioneers in the Canadian medical cannabis industry.

2016 - Established Tikun Olam USA operating in Delaware, Nevada, Washington, Rhode Island, Maryland, Massachusetts and Illinois.

2017 - Co founded  Medifarm Australia; Queensland’s first licensed medicinal cannabis developer.

2018 - Entering European market.


Our company's founding vision continues to drive us to provide patients with unparalleled treatment alternatives through the development of industry-leading professional standards. We are committed to growing and treating patients with the high quality medical grade cannabis.

Leaders in Research

One of the most important aspects of our work is our involvement in research studies that examine the application of our cannabis strains and products in treating patients with various conditions and symptoms. Our research initiatives are published in professional medical journals with the goal of sharing knowledge and spreading awareness about the benefits of medical cannabis treatment and our belief in the importance of professional transparency and open collaboration.

Operating for over a decade, Tikun Olam's products have been used in ongoing clinical trials in Israel's regulated medical cannabis market, treating over 20,000 patients for a variety of medical conditions. Tikun Olam's peer-reviewed scientific research and unprecedented accumulated clinical data, achieved exceptional results and unparalleled success.

Professor Zvi Bentwich, chief scientist, is a leading AIDS researcher, board member of Physicians for Human Rights, and the first doctor in Israel to treat with medical cannabis. Tikun Olam’s research team is led by Lihi Bar-Lev Schleider, a PhD student at the Ben-Gurion University of the Negev, conducting strong partnerships with leading institutions.

Quality and Excellence in Production

Tikun Olam has developed a unique range of proprietary cannabis varieties and innovative products based on unique world-renowned production techniques that focus on increasing the efficacy of the active ingredients in the plant. Our unique varieties have made waves throughout the world and have garnered a lot of attention from international media sources. Our varieties are being utilized in various clinical medical trials based on their safety and efficacy and provide relief for thousands of patients. 

Our medical grade cannabis is grown in a carefully monitored and controlled strict environment, from breeding through harvesting and processing and all the way to the patient. 

Analytical Laboratory 
Tikun Olam’s laboratory managed by Dr Hagit Yariv, specializes in extraction and isolation of active compounds, terpenes and solvent residues, allowing a complete control of the concentrations of compounds in the company’s products and the development of new strains and product, treating specific clinical conditions. Using high-end technologies with state of the art equipment including the HPLC cannabinoid separation device and GC gas chromatograph.
Laboratory is in advanced stages towards accreditation of Standard 17025 by the Laboratory Accreditation Authority.
In addition, regular laboratory tests are conducted at Hebrew University as well as other accredited and advanced external laboratories.                                 

Patient Care Instruction and Follow-Up

We know that an integral part of medical cannabis treatment is empowering patients with access to the professional knowledge to effectively and safely choose, consume the right dose and the right variety customized per patient. To set the patient care standard, we’ve created the world’s first nurse clinic where registered and trained nurses guide patients throughout their treatment course.

Cannabis for Elderly Patients

Tikun Olam founded the first project of its kind in the world to treat elderly patients in the “Hadarim” Nursing Home at Kibbutz Na’an with medical cannabis. With a dedicated staff, professional knowledge, appropriate medical equipment and our vast experience we developed the capacity to overcome the challenges inherent to treating the elderly population with cannabis successfully.

Cannabis for Pediatric Patients

 In accordance with the company’s mission to provide treatment for special and vulnerable population segments, we’ve developed unique products especially for sick children that are easily and safely consumed and have also set up a pediatric nursing department with experienced professionals that oversee our younger patients and make sure that they receive the highest level of care and relief possible.

The Largest Treatment Databases in the World

Tikun Olam has built one of the world’s largest medical cannabis treatment databases that has optimal strain and dose information for many different diseases and information about the reduction of conventional medicines. All of the information is stored anonymously and discretely and forms the basis of our professional nursing staff’s ability to help patients choose the strain and dose that is right for them.

International Connections

Over the years, Tikun Olam has fostered relationships with physicians, researchers, hospitals, and nursing treatment facilities throughout Israel and abroad. Tikun Olam is the exclusive partner of Medreleaf Corp. in Canada and has established knowledge agreements in Spain.

Outreach and Education

Tikun Olam has appeared in hundreds of news and media outlets and invests a lot of effort in outreach to increase awareness amongst doctors, patients, and the general public about the health benefits of treating patients with medical cannabis. The company continues to challenge itself to raise the bar and set the standard of treatment. We want to reach every patient that could benefit from medical cannabis as a real alternative to conventional medical treatment.

Quality Control

The company was awarded ISO 9001 accreditation for the growing, production, sale and distribution of medical grade cannabis, as well as, patient instruction and care in 2012. The following year, the company also received HACCP accreditation for food production safety.